Ghyslain Mombo-Ngoma is an expert in Infectiology at University Medical Center Hamburg-Eppendorf (Germany). As of October 2026, ScienceLeadR ranks Ghyslain Mombo-Ngoma in the top 1% of experts worldwide for Mosquito-Borne Diseases. Ghyslain Mombo-Ngoma has authored 138 publications, the most recent in 2026, and is an investigator in 18 clinical trials. SLR score: 534 (community average: 125). How the SLR is computed.

LeadR Profile

534 ScienceLeadR Reputation 534
Network Map

Infectiology

Subspecialties: Pharmacy - Public Health - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Centre de Recherche Médicales de Lambaréné

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 138

Citations

Citations: 2 825 1st author: 12 Last author: 9 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS-CoV-2.
PMID 42821620 — interferon-gamma, cells, sars-cov-2, loiasis, severe acute respiratory syndrome-related coronavirus, t-lymphocytes, infections
PLoS Negl Trop Dis20260
Association between number of previous malaria episodes and treatment failure among children and adults with laboratory-confirmed Plasmodium infection treated with pyronaridine-artesunate in Gabon: a retrospective cohort study.
PMID 42760579 — malaria, laboratories, cohort studies, treatment failure, therapeutics, artesunate, infections, child
Malar J20260
Safety, pharmacokinetics, and antimalarial efficacy of single-dose cabamiquine-pyronaridine combination therapy for the treatment of adults and adolescents with acute uncomplicated Plasmodium falciparum malaria (CAPTURE 1): a prospective, multicentre, open-label, phase 2a study.
PMID 42462745 — malaria, safety, malaria, falciparum, drug-related side effects and adverse reactions, adolescent, parasites, therapeutics, antimalarials, communicable diseases, pharmacokinetics
Lancet Infect Dis Top journal20263
From the Laboratory to the Field: Assessing the Usability of the NTDscope in the Tropical Rainforest Region of Gabon.
PMID 42335878 — rainforest, laboratories, tropical medicine, therapeutics
Am J Trop Med Hyg20260
Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.
PMID 42283563 — pregnant women, malaria, pregnancy, blood, pharmaceutical preparations, lamivudine, drug therapy, hiv, therapeutics, antiviral agents
Antimicrob Agents Chemother20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 7
N/A 4
Phase 4 3
Phase 3 2
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 15
Terminated 2
Unknown 1

By type:

Interventional 17
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 5
multicentric5to9 6
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map